FI954232A0 - Siiloitettu amyloosi sideaineena/hajotusaineena tableteissa - Google Patents

Siiloitettu amyloosi sideaineena/hajotusaineena tableteissa

Info

Publication number
FI954232A0
FI954232A0 FI954232A FI954232A FI954232A0 FI 954232 A0 FI954232 A0 FI 954232A0 FI 954232 A FI954232 A FI 954232A FI 954232 A FI954232 A FI 954232A FI 954232 A0 FI954232 A0 FI 954232A0
Authority
FI
Finland
Prior art keywords
tablets
binder
crosslinked amylose
antibonding
agent
Prior art date
Application number
FI954232A
Other languages
English (en)
Swedish (sv)
Other versions
FI954232A (fi
Inventor
Louis Cartilier
Mircea A Mateescu
Yves Dumoulin
Vincent Lenaerts
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of FI954232A publication Critical patent/FI954232A/fi
Publication of FI954232A0 publication Critical patent/FI954232A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI954232A 1993-03-25 1995-09-08 Siiloitettu amyloosi sideaineena/hajotusaineena tableteissa FI954232A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/037,119 US5616343A (en) 1993-03-25 1993-03-25 Cross-linked amylose as a binder/disintegrant in tablets
PCT/CA1994/000163 WO1994021236A1 (en) 1993-03-25 1994-03-22 Cross-linked amylose as a binder/disintegrant in tablets

Publications (2)

Publication Number Publication Date
FI954232A FI954232A (fi) 1995-09-08
FI954232A0 true FI954232A0 (fi) 1995-09-08

Family

ID=21892532

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954232A FI954232A0 (fi) 1993-03-25 1995-09-08 Siiloitettu amyloosi sideaineena/hajotusaineena tableteissa

Country Status (17)

Country Link
US (1) US5616343A (fi)
EP (1) EP0689429B1 (fi)
JP (1) JP2831851B2 (fi)
CN (1) CN1119828A (fi)
AT (1) ATE141046T1 (fi)
AU (1) AU679732B2 (fi)
CA (1) CA2155210A1 (fi)
CZ (1) CZ285201B6 (fi)
DE (1) DE69400356T2 (fi)
ES (1) ES2091142T3 (fi)
FI (1) FI954232A0 (fi)
GR (1) GR3021433T3 (fi)
HU (1) HUT73667A (fi)
NO (1) NO953767D0 (fi)
NZ (1) NZ262876A (fi)
PL (1) PL310815A1 (fi)
WO (1) WO1994021236A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19640062B4 (de) * 1996-09-28 2006-04-27 Lts Lohmann Therapie-Systeme Ag Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
AU7501398A (en) * 1997-05-21 1998-12-11 Warner-Lambert Company Non-sedating acrivastine preparation
CA2217238C (en) * 1997-10-24 2005-09-20 Louis Cartilier Cross-linked cellulose as a tablet excipient
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US6660303B2 (en) 1999-12-06 2003-12-09 Edward Mendell & Co. Pharmaceutical superdisintegrant
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US6846497B2 (en) 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
WO2005018678A1 (ja) * 2003-08-26 2005-03-03 Ezaki Glico Co., Ltd. 錠剤用添加剤
NO319624B1 (no) * 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US8871270B2 (en) * 2004-07-09 2014-10-28 Corn Products Development, Inc Tablet excipient
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
EP1717215A1 (fr) * 2005-04-19 2006-11-02 Lafarge Procédé de compaction de liant hydraulique et compacts broyés
RU2008113439A (ru) * 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
KR20100069685A (ko) * 2007-10-16 2010-06-24 라보팜 인코포레이트 아세트아미노펜과 트라마돌의 지속 방출을 위한 이중층 조성물
AU2008338207A1 (en) 2007-12-17 2009-06-25 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
CN101981059B (zh) * 2008-03-31 2014-08-20 旭化成化学株式会社 具有出色的崩解性能的经加工的淀粉粉末及其制造方法
EP2367541B1 (en) * 2008-12-16 2014-07-16 Paladin Labs Inc. Misuse preventative, controlled release formulation
AU2011276170B2 (en) 2010-07-06 2016-03-10 Grunenthal Gmbh Novel gastro- retentive dosage forms comprising a GABA Analog and an opioid
US20120015031A1 (en) 2010-07-14 2012-01-19 Grunenthal Gmbh Novel gastro-retentive dosage forms
CN108456050A (zh) * 2018-01-24 2018-08-28 天津水泥工业设计研究院有限公司 一种低成本的生产圆颗粒矿物肥料的造粒添加剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US4755397A (en) * 1986-12-24 1988-07-05 National Starch And Chemical Corporation Starch based particulate encapsulation process
US4812445A (en) * 1987-02-06 1989-03-14 National Starch And Chemical Corporation Starch based encapsulation process
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
CA2032385A1 (en) * 1990-12-17 1992-06-18 Chung Wai-Chiu Enzymatically debranched starches as tablet excipients

Also Published As

Publication number Publication date
CN1119828A (zh) 1996-04-03
CA2155210A1 (en) 1994-09-29
DE69400356T2 (de) 1996-11-28
FI954232A (fi) 1995-09-08
HU9502790D0 (en) 1995-11-28
ATE141046T1 (de) 1996-08-15
CZ285201B6 (cs) 1999-06-16
ES2091142T3 (es) 1996-10-16
GR3021433T3 (en) 1997-01-31
PL310815A1 (en) 1996-01-08
NZ262876A (en) 1997-01-29
HUT73667A (en) 1996-09-30
EP0689429A1 (en) 1996-01-03
AU6279994A (en) 1994-10-11
JPH08507769A (ja) 1996-08-20
WO1994021236A1 (en) 1994-09-29
DE69400356D1 (de) 1996-09-12
NO953767L (no) 1995-09-22
JP2831851B2 (ja) 1998-12-02
EP0689429B1 (en) 1996-08-07
NO953767D0 (no) 1995-09-22
AU679732B2 (en) 1997-07-10
US5616343A (en) 1997-04-01
CZ248695A3 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
FI954232A0 (fi) Siiloitettu amyloosi sideaineena/hajotusaineena tableteissa
NO20004208L (no) Fornettet stivelse med høyt amyloseinnhold og med funksjonelle grupper som en matriks for frigivning av farmasøytiske midler
MY125516A (en) Novel composition based on thiazolidinedione and metformin and use
MA22102A1 (fr) Compositions polymeres absorbantes particulaires contenant des agregats reticules interparticulaires .
DK0929565T3 (da) Nitratestere af corticoidforbindelser og farmaceutiske anvendelser deraf
ATE239709T1 (de) Racemisches huperzin a
TR199900161T2 (xx) T�bbi �r�nler �retimi i�in aminler.
ES2086949T3 (es) Material polihidroxilico reticulado para liberacion de farmaco enzimaticamente controlada.
DE69927374D1 (de) Entzündungshemmende pharmazeutische formulierungen
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
PT1017667E (pt) 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria
ES2165970T3 (es) Forma farmaceutica solida con principio activo distribuido en un material polimerico.
ECSP961978A (es) 1- fenil- 2- dimetil-amino - metil ciclohexan ol, a procedimientos para su preparacion y la aplicación de estos compuestos en medicamentos